Tailoring tacrolimus therapy in kidney transplantation.

CONCLUSION: tacrolimus-based immunosuppression is still the best immunosuppressive therapy in kidney transplant recipients, and can be tailored according to patients'need. PMID: 29779413 [PubMed - as supplied by publisher]
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research